Pten gene mutations are seen in high grade, but not in low grade gliomas.

被引:0
|
作者
Stenzel, TT
Rasheed, BKA
McLendon, RE
Parsons, R
Friedman, AH
Friedman, HS
Bigner, SH
机构
[1] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710
[4] COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY
[5] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [21] Chromatin mutations in pediatric high grade gliomas
    Voon, Hsiao P. J.
    Wong, Lee H.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [22] Grading of pediatric high grade gliomas. Results from the HERBY trial
    Varlet, Pascale
    Le Teuff, Gwenael
    Le Deley, Marie-Cecile
    Giangaspero, Felice
    Haberler, Christine
    Jacques, Thomas
    Figarella-Branger, Dominique
    Pietsch, Torsten
    Andreiuolo, Felipe
    Grill, Jacques
    BRAIN PATHOLOGY, 2019, 29 : 57 - 57
  • [23] Bevacizumab plus irinotecan in patients with recurrent high grade malignant gliomas.
    Legaspi, Jairo
    Ceniceros, Lucia
    Espinos, Jaime
    Valtuena, German
    Martin, Patricia
    Castanon Alvarez, Eduardo
    Aristu, Javier
    Baraibar, Iosune
    Salas, Diego
    Sala, Pablo
    Gardeazabal, Itziar
    Zubiri Oteiza, Leyre
    Olarte, Alicia
    Gil-Bazo, Ignacio
    Dominguez, Pablo
    Pablo Fusco, Juan
    Isabel Martinez, Maria
    Aramendia, Jose M.
    Fernandez-Hidalgo, Oscar
    Santisteban, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Dynamic genomic deletion expansion: A molecular marker of high grade gliomas.
    Finkelstein, SD
    Swalsky, PA
    Wilson, MM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 454 - 454
  • [25] Precise volume measurements of low-grade gliomas.: Some surprising findings
    Rees, JH
    Benton, C
    Watt, H
    Fox, NCI
    Waldman, A
    Jäger, HR
    Stevens, J
    Tofts, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (03): : 518 - 519
  • [26] Gene expression signature to predict radiation response in lower-grade gliomas.
    Qian, David C.
    Marascio, Joseph A.
    Neill, Stewart G.
    Hoang, Kimberly B.
    Olson, Jeffrey J.
    Eaton, Bree R.
    Shu, Hui-Kuo George
    Zhong, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Isocitrate dehydrogenase mutations in low-grade gliomas
    David Schiff
    Benjamin W. Purow
    Nature Reviews Neurology, 2009, 5 : 303 - 304
  • [28] IDH MUTATIONS AND THEIR ROLE IN PROGRESSION OF LOW GRADE GLIOMAS
    Juratli, Tareq A.
    Kirsch, Matthias
    Schackert, Gabriele
    Krex, Dietmar
    NEURO-ONCOLOGY, 2011, 13 : 51 - 51
  • [29] Isocitrate dehydrogenase mutations in low-grade gliomas
    Schiff, David
    Purow, Benjamin W.
    NATURE REVIEWS NEUROLOGY, 2009, 5 (06) : 303 - 304
  • [30] Use of Tegwondo, a near-continuous temozolomide regimen, in high- and low-grade gliomas.
    Strik, H. M.
    Bock, H. C.
    Marosi, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)